The Lysophosphatidic Acid Receptor LPA1 Promotes Epithelial Cell Apoptosis after Lung Injury
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Increased epithelial cell apoptosis in response to lung injury has been implicated in the development of idiopathic pulmonary fibrosis (IPF), but the molecular pathways promoting epithelial cell apoptosis in this disease have yet to be fully identified. Lysophosphatidic acid (LPA), which we have previously demonstrated to mediate bleomycin lung injury–induced fibroblast recruitment and vascular leak in mice and fibroblast recruitment in patients with IPF, is an important regulator of survival and apoptosis in many cell types. We now show that LPA signaling through its receptor LPA1 promotes epithelial cell apoptosis induced by bleomycin injury. The number of apoptotic cells present in the alveolar and bronchial epithelia of LPA1–deficient mice was significantly reduced compared with wild-type mice at Day 3 after bleomycin challenge, as was lung caspase-3 activity. Consistent with these in vivo results, we found that LPA signaling through LPA1 induced apoptosis in normal human bronchial epithelial cells in culture. LPA-LPA1 signaling appeared to specifically mediate anoikis, the apoptosis of anchorage-dependent cells induced by their detachment. Similarly, LPA negatively regulated attachment of R3/1 rat alveolar epithelial cell line cells. In contrast, LPA signaling through LPA1 promoted the resistance of lung fibroblasts to apoptosis, which has also been implicated in IPF. The ability of LPA-LPA1 signaling to promote epithelial cell apoptosis and fibroblast resistance to apoptosis may therefore contribute to the capacity of this signaling pathway to regulate the development of pulmonary fibrosis after lung injury.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In pulmonary fi brosis, lysophosphatidic acid receptor 1 (LPA1) activation is associated with fi broblast recruitment, activation/proliferation, and survival, as well as epithelial cell apoptosis, all of which drive lung fi brosis progression (8, 9).”
From Efficacy and Safety of Admilparant, an LPA1 Antagonist, in Pulmonary Fibrosis: A Phase 2 Randomized Clinical Trial. (2025) · cites this paper as [9]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Disruption of epithelial cell-matrix interactions induces apoptosis
Frisch, S., & Francis, H. (1994) · The Journal of cell biology · doi:10.1083/jcb.124.4.619 · Cited by 3,254
Selman, M., King, T. E., & Pardo, A. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-2-200101160-00015 · Cited by 1,786
Kim, K. K., Kugler, M. C., Wolters, P. J., Robillard, L., Galvez, M. G., Brumwell, A. N., Sheppard, D., & Chapman, H. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605669103 · Cited by 1,257
LPA Receptors: Subtypes and Biological Actions
Choi, J. W., Herr, D. R., Noguchi, K., Yung, Y. C., Lee, C.-W., Mutoh, T., Lin, M.-E., Teo, S. T., Park, K. E., Mosley, A. N., et al. (2010) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105753 · Cited by 839
Self-citationTager, A. M., LaCamera, P., Shea, B. S., Campanella, G. S., Selman, M., Zhao, Z., Polosukhin, V., Wain, J., Karimi-Shah, B. A., Kim, N. D., et al. (2008) · Nature Medicine · doi:10.1038/nm1685 · Cited by 823
Self-citationGilmore, A. P. (2005) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401723 · Cited by 597
Inflammatory mediators in acute pancreatitis
Bhatia, M., Brady, M., Shokuhi, S., Christmas, S., Neoptolemos, J. P., & Slavin, J. (2000) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(200002)190:2<117::aid-path494>3.0.co;2-k · Cited by 534
Anoikis: A necessary death program for anchorage-dependent cells
Chiarugi, P., & Giannoni, E. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.07.023 · Cited by 494
Requirement for the lp A1 lysophosphatidic acid receptor gene in normal suckling behavior
Contos, J. J. A., Fukushima, N., Weiner, J. A., Kaushal, D., & Chun, J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.24.13384 · Cited by 479
Self-citationTargeted Injury of Type II Alveolar Epithelial Cells Induces Pulmonary Fibrosis
Sisson, T. H., Mendez, M., Choi, K., Subbotina, N., Courey, A., Cunningham, A., Dave, A., Engelhardt, J. F., Liu, X., White, E. S., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200810-1615oc · Cited by 474
Research works printed but not linked: 1
- Funke M, Shea BS, Groom J, Castelino F, Brooks SF, Chun J, Tager AM. Lysophosphatidic acid contributes to an apoptosis paradox in lung fibrosis [abstract]. Am J Respir Crit Care Med 2009;:A1988 [Google Scholar]
Cited by
Items 101–156 of 156
Isshiki, T., Shimizu, H., Sakamoto, S., Yamasaki, A., Miyoshi, S., Nakamura, Y., Homma, S. A., & Kishi, K. (2022) · ERJ Open Research · doi:10.1183/23120541.00683-2021 · Cited by 9
Regulation of silicosis formation by lysophosphatidic acid and its receptors
Cong, C., Mao, L., Zhang, Y., Zhao, Z., Xu, X.-X., & Zhao, J. (2014) · Experimental Lung Research · doi:10.3109/01902148.2014.920438 · Cited by 9
Self-citationShim, G. H., Kim, H. J., Kim, E. S., Lee, K.-Y., Kim, E.-K., & Choi, J. (2015) · Free Radical Research · doi:10.3109/10715762.2015.1073850 · Cited by 9
Yang, L., Shu, P., Wu, N., Hu, M., & Luo, Z. (2023) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2023.106552 · Cited by 8
Tang, D. T. Y., Du, Z., Yang, K. S., Bestvater, B. P., Kaplan, J. A., Neubig, M. E., Olen, C. L., Phillips, B., Wang, P., Hudson, T. E., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c02090 · Cited by 8
Emerging Concepts in Therapeutic Interventions for Idiopathic Pulmonary Fibrosis
Schott, C. A., Mohning, M. P., & Cooley, J. C. (2025) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/a-2651-1937 · Cited by 7
Froidure, A., Joannes, A., Mailleux, A., & Crestani, B. (2016) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2016.1171140 · Cited by 7
Xie, Y., Wang, Y., Zong, C., & Cheng, J. (2014) · Pharmacology · doi:10.1159/000360638 · Cited by 6
Kong, J., Xiong, Y., Duan, Y., & Zhu, X. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111222 · Cited by 4
Li, N., Xu, X., Qi, Z., Gao, C., Zhao, P., Yang, J., & Damirin, A. (2022) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2021-0331oc · Cited by 4
Hypoxia Promotes Invadosome Formation by Lung Fibroblasts
Lebel, M., Cliché, D. O., Charbonneau, M., Brochu‐Gaudreau, K., Adam, D., Brochiero, E., Dubois, C. M., & Cantin, A. M. (2024) · Cells · doi:10.3390/cells13131152 · Cited by 4
Angiogenic effect of lysophosphatidic acid receptors on cervical cancer cells
Chen, R., Chou, C., Chen, S., & Lee, H. (2015) · Translational Cancer Research · doi:10.21037/5492 · Cited by 4
Targeted therapy for idiopathic pulmonary fibrosis: a bibliometric analysis of 2004–2024
Zhang, X., Yuan, Z., Shi, X., & Yang, J. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1543571 · Cited by 3
ERS International Congress 2023: highlights from the Basic and Translational Sciences Assembly
Reddy, K. V. V. S. N., Bizymi, N., Schweikert, A., Ananth, S., Lim, C. X., Lodge, K. M., Joannes, A., Ubags, N. D. J., van der Does, A. M., Cloonan, S. M., et al. (2023) · ERJ Open Research · doi:10.1183/23120541.00875-2023 · Cited by 3
Pharmacologic Treatment of IPF
Smargiassi, A., Pasciuto, G., Conte, E. G., Andreani, M., Marra, R., & Richeldi, L. (2018) · Respiratory medicine · doi:10.1007/978-3-319-99975-3_13 · Cited by 3
Fibrotic Signaling in the Lung
Dutta, J. A., Bahudhanapati, H., Tan, J., Goldblum, A., & Kass, D. J. (2018) · Molecular and translational medicine · doi:10.1007/978-3-319-98143-7_4 · Cited by 2
Zhao, B. T., Xu, S., Wei, X., Li, Y., Qu, S., Lei, H., & Zhai, X. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.118011 · Cited by 2
Autotaxin concentrations in peritoneal dialysis effluent reflect peritoneal function
Horikoshi, K., Sakai, N., Oshima, M., Yamauchi, H., Ikeda, M., Hayashi, K., Yanagisawa, H., Yamamori, F., Kajikawa, S., Hayashi, D., et al. (2024) · Therapeutic Apheresis and Dialysis · doi:10.1111/1744-9987.14211 · Cited by 2
Chiang, G. C., Ayres, M., Rivas, A., Parker, S. J., Mastali, M., Chen, P., Eyk, J. E. V., Wolters, P. J., Boin, F., & Zaman, T. (2025) · BMC Pulmonary Medicine · doi:10.1186/s12890-024-03474-z · Cited by 2
A Refined Approach to Target the Molecular and Cellular Mechanisms in Pulmonary Fibrosis
Singh, S., Dutta, J., Ray, A., Jaiswal, A. K., & Mabalirajan, U. (2021) · Springer eBooks · doi:10.1007/978-981-33-6827-9_13 · Cited by 2
Advance Genome Disorder Prediction Model Using Deep Learning Algorithms
Ponmalar, S., Priyadharshini, K., Pooja, V., & Swathi, M. (2024) · International Conference for Innovation in Technology (INOCON) · doi:10.1109/inocon60754.2024.10511618 · Cited by 1
Ha, A. W., Sudhadevi, T., Jafri, A., Mayer, C., MacFarlane, P. M., Natarajan, V., & Harijith, A. K. (2024) · Pediatric Research · doi:10.1038/s41390-024-03610-9 · Cited by 1
Kim, K. D., & Yoo, B. C. (2026) · Biomolecules · doi:10.3390/biom16030465 · Cited by 1
Advances in pharmacotherapy for fibrotic interstitial lung disease
Feng, X., Deng, M., Miao, J., Zheng, Z., & Hou, G. (2026) · Medical Review · doi:10.1515/mr-2025-0086 · Cited by 1
Maher, T. M., Kaminski, N., Wang, F., Funke-Chambour, M., Wu, C., Hu, Y., Sharma, S., Schafer, P. H., Schaller, M. A., & Horan, G. S. B. (2026) · Respiratory Research · doi:10.1186/s12931-026-03809-w · Cited by 1
Molecular Systems Architecture of Fibrotic Lung Microenvironment in Idiopathic Pulmonary Fibrosis
Ayyadurai, V. A. S., Manoharan, Y., & Deonikar, P. (2026) · Cells · doi:10.3390/cells15151364 · Cited by 1
Tando, Y., Ota, C., Yamada, M., Kamata, S., Yamaya, M., Kano, K., Okudaira, S., Aoki, J., & Kubo, H. (2015) · Transplantation Direct · doi:10.1097/txd.0000000000000542 · Cited by 1
Autotaxin Inhibitors in Fibrosis
Desroy, N., & Heckmann, B. (2020) · Royal Society of Chemistry eBooks · doi:10.1039/9781788015783-00117 · Cited by 1
Sakai, N., & Tager, A. M. (2013) · Inflammation and Regeneration · doi:10.2492/inflammregen.33.078 · Cited by 1
Self-citationThe FLORA study: presenting a novel IPF trial design
Crestani, B., & Günther, A. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30269-8 · Cited by 1
Loeh, B., Korfei, M., Mahavadi, P., Wasnick, R. M., von der Beck, D., & Günther, A. (2016) · European Respiratory Society eBooks · doi:10.1183/2312508x.10004815 · Cited by 1
He, H., Su, H., Chen, X., Chen, X., & Yang, S. (2024) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2024.106863 · Cited by 1
High CXCL6 drives matrix expression and correlate with markers of poor outcome in IPFPreprint
Bahudhanapati, H., Tan, J., Apel, R. M., Seeliger, B., Li, X., Chen, T., Sullivan, D. I., Sembrat, J., Rojas, M. M., Tabib, T., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.22.449424 · Cited by 1
The role of GPR87 in Pulmonary FibrosisPreprint
Khoury, J., Ahangari, F., Adams, T. S., Justet, A., Manning, E. P., McDonough, J. E., Bärnthaler, T., Anderson, S., Nikola, F., Beermann, M. L., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.10.617569 · Cited by 1
Eymery, M. (2023) · theses.fr (ABES) · doi:10.70675/d89a6883zb802z4d71z97b5z7e742a2dd3e5 · Cited by 1
Lysophospholipid Regulation of Lung Fibrosis
Shea, B. S., & Tager, A. M. (2013) · Wiley eBooks · doi:10.1002/9781118531426.ch27
Self-citationInvestigations into the role of pulmonary innate immunity during fibrotic lung disease
Allden, S. (2018) · Spiral (Imperial College London) · doi:10.25560/82070
Lummis, N. C. (2018) · eScholarship (California Digital Library)
López, L. L. (2021) · Repositorio Institucional de la Universidad de Málaga (University of Málaga)
Sandbo, N. K. (2018) · Respiratory medicine · doi:10.1007/978-3-319-99975-3_7
Ijaz, F., Imami, K., & Ikegami, K. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.20.671189
Li, Q., Wong, W., Birnberg, A., Chakrabarti, A., Yang, X., Choy, D. F., Olsson, J. K., Verschueren, E., Neighbors, M., Sandoval, W., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16674917
Muc1 bioactivation contributes to lung fibrosis
Ballester Llobell, B. (2019) · Repository of Digital Objects for Teaching Research and Culture (University of Valencia)
Autotaxin concentrations in peritoneal dialysis effluent reflect peritoneal function
Horikoshi, K., & Keisuke, H. (2025) · Institutional Repositories DataBase (IRDB)
Nazemi, N., Crestani, B., Helou, D. G., Distler, O., Gote-Schniering, J., Vold, A., Machahua, C., Kolb, M. R. J., & Funke-Chambour, M. (2026) · European Respiratory Journal · doi:10.1183/13993003.00258-2026
細胞の増殖・分化に関わる生理活性物質シグナル制御に着目した疾患治療戦略に関する研究
成瀨, 巧. (2023) · Institutional Repositories DataBase (IRDB) · doi:10.15083/0002012398
Advances in metabolic reprogramming of pulmonary fibrosis
Zhou, H., & Zhang, T. (2026) · Chinese Medical Journal - Pulmonary and Critical Care Medicine · doi:10.1016/j.pccm.2026.07.003
BindingDB (2017) · UC San Diego · doi:10.7270/q2bz681d
BindingDB (2019) · UC San Diego · doi:10.7270/q29c70v2
BindingDB (2020) · UC San Diego · doi:10.7270/q25141pd
Rancoule, C. (2013) · Thèses en ligne de l'Université Toulouse III (Université Toulouse III)
Metadata
- Authors
- Funke, M., Zhao, Z., Xu, Y., Chun, J., & Tager, A. M.
- Affiliations
- Harvard University (US)
- Indiana University School of Medicine (US)
- Scripps Research Institute (US)
- Corresponding author
- Tager, Andrew M.
- Venue
- American Journal of Respiratory Cell and Molecular Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-03-01
- Volume
- 46
- Issue
- 3
- Pages
- 355-364
- ISSN
- 1044-1549 (ISSN-L)
- 1535-4989
- PMC
- PMC3326436
- OpenAlex
- W2114232709
- Cited by
- 141
- References
- 49
- Citations by year
- 2026: 5 · 2025: 11 · 2024: 12 · 2023: 12 · 2022: 5 · 2021: 10 · 2020: 8 · 2019: 8 · 2018: 11 · 2017: 5 · 2016: 10 · 2015: 10 · 2014: 8 · 2013: 11 · 2012: 14
- FWCI
- 9.25
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- American Journal of Respiratory Cell and Molecular Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- BORIS (University Library Bern) (submittedVersion)
- Funders
- National Institutes of Health (5r01da019674-05)
- National Heart, Lung, and Blood Institute (R01HL095732, R01HL108975)
- National Institute on Drug Abuse (NIH-DA019674, R01-DA019674)
- National Cancer Institute (R01CA095042)
- National Institute of Allergy and Infectious Diseases (P30AI060354)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NIH-HD050685, R01HD050685)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Keywords
- lysophosphatidic acid, LPA1 receptor, epithelial apoptosis, lung injury, idiopathic pulmonary fibrosis, bleomycin-induced lung injury, anoikis, caspase-3, alveolar epithelial cells, bronchial epithelial cells, lung fibroblasts, LPA signaling
- MeSH terms
- Animals, Bleomycin, Cell Adhesion, Cells, Cultured, Disease Models, Animal, Epithelial Cells, Fibroblasts, Humans, Lung, Lysophospholipids, Mice, Inbred C57BL, Pulmonary Fibrosis, Time Factors, Signal Transduction, Apoptosis, Mice, Knockout, Anoikis, Receptors, Lysophosphatidic Acid, Mice, Rats, Caspase 3, Lung Injury, Mice, 129 Strain
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.